Curaleaf Holdings, Inc. (CURLF): R&D Expense
$805.0K
Year ended 2025-12-31
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $805.0K | -43.3% | 2026-02-27, From 2025-01-01 |
| 2024-12-31 | $1.42M | n/a | 2026-02-27, From 2024-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Curaleaf Holdings, Inc. (CURLF) | 2025-12-31 | $805.0K | -43.3% |
| USANA Health Sciences Inc (USNA) | 2026-01-03 | $10.69M | -7.6% |
| Tilray Brands, Inc. (TLRY) | 2026-05-31 | $361.0K | +27.1% |
| Cronos Group Inc. (CRON) | 2025-12-31 | $4.45M | +5.2% |
| Natural Alternatives International Inc (NAII) | 2025-06-30 | $1.80M | -5.3% |
| Niagen Bioscience, Inc. (NAGE) | 2025-12-31 | $6.33M | +5.2% |
| Mannatech Inc (MTEX) | 2025-12-31 | $800.0K | +14.3% |
| Leef Brands Inc. (LEEEF) | 2025-12-31 | $19.7K | +3.8% |
| Cyanotech Corp (CYAN) | 2025-03-31 | $449.0K | -34.8% |
Compare CURLF, USNA, TLRY, CRON side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗